Experts call for stronger safety rules in bacteria based cancer trials
Original title: Perspective on Lessons Not Learned: From Coley's Toxins to Microbial Drug Delivery, Guidance for Institutional Review Boards (IRBs).
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is expert opinion about how to run trials safely, not a new treatment.
The short version
Doctors are warning that trials using bacteria or bacterial toxins against brain tumors need much stricter safety planning.
What was studied. This is an opinion paper, not a new study. The authors look back at 130 years of treating cancer with bacteria and bacterial toxins. They suggest what ethics review boards should require before approving these trials in people.
What they found. The authors say this approach is being tried again, and glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary is one of the main cancers being targeted. They warn that the human immune system reacts to bacterial toxins very differently than animals do. Humans are 330 to 200,000 times more sensitive to these toxins than mice and rats. They say animal results, even in monkeys, can be misleading, and that poor planning for risk will likely cause deaths.
What this means, and what it doesn't
What it could mean: If you are offered a trial that uses live bacteria or bacterial toxins, it is fair to ask the team how they plan for safety. The authors think injecting a measured amount of a toxin into a set spot may be safer than using live bacteria. Good results in animals do not mean the same dose is safe for a person.
What it doesn't mean: This is not a new treatment and not a new result. It is expert opinion and advice for the boards that approve trials. It does not show that any bacteria based treatment works against brain tumors. It is not a cure, and it is a long way from everyday care.
Source: PubMed, July 3, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.